Eulav Asset Management Biomarin Pharmaceutical Inc Transaction History
Eulav Asset Management
- $3.64 Billion
- Q1 2024
A detailed history of Eulav Asset Management transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Eulav Asset Management holds 121,800 shares of BMRN stock, worth $10 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
121,800
Previous 130,000
6.31%
Holding current value
$10 Million
Previous $12.5 Million
15.13%
% of portfolio
0.29%
Previous 0.39%
Shares
21 transactions
Others Institutions Holding BMRN
# of Institutions
623Shares Held
181MCall Options Held
1.73MPut Options Held
1.73M-
Primecap Management CO Pasadena, CA18.7MShares$1.54 Billion1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$1.49 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.19 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14MShares$1.15 Billion0.75% of portfolio
-
State Street Corp Boston, MA6.9MShares$568 Million0.03% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...